Compare Equinix Inc (EQIX) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinix Inc vs IDEXX Laboratories, Inc. — how do they compare? Equinix Inc trades at $1,026.06 (market cap $99.77B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: Equinix Inc is far larger — about 2.5× IDEXX Laboratories, Inc.'s market cap, and Equinix Inc pays a 2.04% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Equinix Inc for 110 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| EQIX | IDXX | |
|---|---|---|
Market Cap | $99.77B | $40.43B |
Volume | 480,425 | 692,164 |
Sector | Real Estate | Health |
52-Week High | $1.12K | $766.68 |
52-Week Low | $726.09 | $504.70 |
Typical Hold Time | 110 Days | 46 Days |
Enterprise Value | $120.90B | $41.32B |
Dividend Yield | 2.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Equinix (EQIX) trades at $1,011.16, down 2.0% on the day amid a bearish technical signal. The stock shows strong fundamentals with revenue growth to $9.22B in 2025 and a net income margin of 15.63%, though valuation ratios like a P/E of 65.07 appear elevated. Recent earnings have been mixed, with Q2 2026 beating expectations but Q1 and Q4 2025 missing. Analyst sentiment remains bullish with a $1,250 consensus price target, supported by strong AI-driven data center demand highlighted in recent news.
The outlook for EQIX is positive due to robust AI infrastructure demand and a solid dividend, but risks include high capital expenditures and debt levels. Investors should weigh growth potential against valuation concerns and execution risks in a competitive sector.
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Equinix Inc
Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.
Read more on EQIX →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
